These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27497990)

  • 1. Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.
    Ferrari M; Comi C; Marino F; Magistrelli L; De Marchi F; Cantello R; Riboldazzi G; Bono G; Cosentino M
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1335-1341. PubMed ID: 27497990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease.
    Comi C; Ferrari M; Marino F; Magistrelli L; Cantello R; Riboldazzi G; Bianchi ML; Bono G; Cosentino M
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28125015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
    Goetz CG; Burke PF; Leurgans S; Berry-Kravis E; Blasucci LM; Raman R; Zhou L
    Arch Neurol; 2001 Feb; 58(2):209-13. PubMed ID: 11176958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.
    Cosentino M; Ferrari M; Kustrimovic N; Rasini E; Marino F
    Hum Immunol; 2015 Oct; 76(10):747-52. PubMed ID: 26429319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
    Zainal Abidin S; Tan EL; Chan SC; Jaafar A; Lee AX; Abd Hamid MH; Abdul Murad NA; Pakarul Razy NF; Azmin S; Ahmad Annuar A; Lim SY; Cheah PS; Ling KH; Mohamed Ibrahim N
    BMC Neurol; 2015 Apr; 15():59. PubMed ID: 25896831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.
    Wang J; Zhao C; Chen B; Liu ZL
    Neurosci Lett; 2004 Jan; 355(3):193-6. PubMed ID: 14732464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
    Goldman JG; Goetz CG; Berry-Kravis E; Leurgans S; Zhou L
    Arch Neurol; 2004 Aug; 61(8):1280-4. PubMed ID: 15313848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Categorising Visual Hallucinations in Early Parkinson's Disease.
    Clegg BJ; Duncan GW; Khoo TK; Barker RA; Burn DJ; Yarnall AJ; Lawson RA
    J Parkinsons Dis; 2018; 8(3):447-453. PubMed ID: 30040741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease.
    Zhu J; Shen B; Lu L; Lan W; Pan Y; Zhang L; Dong J; Wang M; Zhang L
    J Neurol Sci; 2017 Jan; 372():471-476. PubMed ID: 27823833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP levels in lymphocytes and CD4
    Cosentino M; Kustrimovic N; Ferrari M; Rasini E; Marino F
    Immunology; 2018 Mar; 153(3):337-341. PubMed ID: 28940477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.
    Kiferle L; Ceravolo R; Petrozzi L; Rossi C; Frosini D; Rocchi A; Siciliano G; Bonuccelli U; Murri L
    Neurosci Lett; 2007 Jul; 422(3):228-31. PubMed ID: 17614196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 2A receptors and visual hallucinations in Parkinson disease.
    Ballanger B; Strafella AP; van Eimeren T; Zurowski M; Rusjan PM; Houle S; Fox SH
    Arch Neurol; 2010 Apr; 67(4):416-21. PubMed ID: 20385906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for visual hallucinations in patients with Parkinson's disease.
    Gama RL; de Bruin VM; de Bruin PF; Távora DG; Lopes EM; Jorge IF; Bittencourt LR; Tufik S
    Neurol Res; 2015 Feb; 37(2):112-6. PubMed ID: 25002179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT study.
    Kiferle L; Ceravolo R; Giuntini M; Linsalata G; Puccini G; Volterrani D; Bonuccelli U
    Parkinsonism Relat Disord; 2014 Jul; 20(7):761-5. PubMed ID: 24787757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease.
    Kurita A; Ochiai Y; Kono Y; Suzuki M; Inoue K
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):184-8. PubMed ID: 12967063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease.
    Damasceno Dos Santos EU; Duarte EBC; Miranda LMR; Asano AGC; Asano NMJ; Maia MMD; de Souza PRE
    J Clin Pharmacol; 2019 Jul; 59(7):1006-1013. PubMed ID: 30794329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.
    Makoff AJ; Graham JM; Arranz MJ; Forsyth J; Li T; Aitchison KJ; Shaikh S; Grünewald RA
    Pharmacogenetics; 2000 Feb; 10(1):43-8. PubMed ID: 10739171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic substrates of psychosis in patients with Parkinson's disease: A critical review.
    Lenka A; Arumugham SS; Christopher R; Pal PK
    J Neurol Sci; 2016 May; 364():33-41. PubMed ID: 27084212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.